Ra Medical Systems, Inc. (RMED) financial statements (2021 and earlier)

Company profile

Business Address 2070 LAS PALMAS DRIVE
CARLSBAD, CA 92011
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:243164
Cash and cash equivalents241564
Other undisclosed cash, cash equivalents, and short-term investments 16 
Receivables011
Inventory, net of allowances, customer advances and progress billings232
Inventory232
Other undisclosed current assets122
Total current assets:283669
Noncurrent Assets
Operating lease, right-of-use asset23
Property, plant and equipment355
Other noncurrent assets000
Total noncurrent assets:685
TOTAL ASSETS:334474
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities544
Accounts payable121
Accrued liabilities433
Deferred revenue22
Debt00 
Contract with customer, liability2
Other undisclosed current liabilities100
Total current liabilities:876
Noncurrent Liabilities
Long-term debt and lease obligation23 
Operating lease, liability23
Liabilities, other than long-term debt111
Deferred revenue11
Contract with customer, liability1
Other liabilities  0
Other undisclosed noncurrent liabilities201
Total noncurrent liabilities:541
Total liabilities:12117
Stockholders' equity
Stockholders' equity attributable to parent213367
Common stock000
Additional paid in capital174150127
Accumulated other comprehensive income 0 
Accumulated deficit(153)(117)(60)
Total stockholders' equity:213367
TOTAL LIABILITIES AND EQUITY:334474

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues476
Cost of revenue
(Cost of Goods and Services Sold)
(5)(9)(4)
Gross profit:(1)(2)2
Operating expenses(35)(56)(33)
Operating loss:(36)(58)(31)
Nonoperating income010
Investment income, nonoperating010
Interest and debt expense(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(36)(57)(31)
Other undisclosed income from continuing operations before income taxes000
Loss from continuing operations before income taxes:(36)(57)(31)
Income tax expense(0)(0)(0)
Net loss available to common stockholders, diluted:(36)(57)(31)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(36)(57)(31)
Other comprehensive income (loss)(0)0 
Comprehensive loss, net of tax, attributable to parent:(36)(57)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: